Jeff Hunnicutt, Chief Executive Officer at Highlands Oncology Group, reshared a post by Michal Meiri,Co-Founder and CEO at Agamon Healtn, on LinkedIn:
“Most oncology groups are shifting away from trying to understand ePRO and toward working through how to put into practice.
This recent work from the American Society of Clinical Oncology (ASCO) is a good reminder that this is no longer optional. The evidence is clear. When patient-reported symptoms are captured in real time, care becomes more proactive, outcomes improve, and avoidable utilization goes down.
What stood out to me is that this isn’t really a technology problem. It’s an execution one.
Who is reviewing the information? How quickly are teams expected to respond? What happens after an alert is triggered?
Those decisions determine whether ePRO actually changes care or just creates more noise.
This is moving quickly from ‘nice to have’ to an expected part of oncology care. The practices that figure out how to operationalize it well will be in a very different position than those that don’t.”
Title: Supporting Reimbursement for Electronic Patient-Reported Outcomes in Clinical Cancer Care Using Current Procedural Terminology Codes for Remote Therapeutic Monitoring
Authors: Gabrielle Rocque, Debra Patt, Jeff Hunnicutt, Brian Bourbeau, Rachael Willeford, Allison Hirschorn, Stephanie Crist, Ethan Basch
Read The Full Article
Other articles about ASCO on OncoDaily.